Live Quote · NASDAQIMVTHealthcare· Biotechnology

Immunovant, Inc.

$31.77▼ 2.31%($-0.75)
MKT CAP $6.57BNEXT EARNINGS Feb 5, 2027
50%
Bullish
TickerSpark Score
43/100
▌ Weak
40
Valuation
40
Profitability
20
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMVT research report →

Analyst Price Target
$40.00+25.9% vs. today

Range $40 – $40

Analyst RatingBuy
18 Buy4 Hold1 Sell

Price Chart

+41.07% · this period
$44.96$33.49$22.02Nov 20May 26Nov 20
52-Week Range42% of range
Low
$21.86
Current
$31.77
High
$45.42